95 related articles for article (PubMed ID: 24060217)
21. Development of sensory tools for green rooibos (Aspalathus linearis (Burm.f.) R.Dahlgren) and changes in quality attributes during shelf-life storage.
de Beer D; Human C; du Preez BV; Moelich EI; van der Rijst M; Joubert E
J Sci Food Agric; 2024 May; ():. PubMed ID: 38779961
[TBL] [Abstract][Full Text] [Related]
22. Effects of an environmentally relevant mixture of organochlorine pesticide compounds on adipogenesis and adipocyte function in an immortalized human adipocyte model.
Howell GE; Young D
Toxicol In Vitro; 2024 Jun; 98():105831. PubMed ID: 38648980
[TBL] [Abstract][Full Text] [Related]
23. Modelling the distribution of Aspalathus linearis (Rooibos tea): implications of climate change for livelihoods dependent on both cultivation and harvesting from the wild.
Lötter D; Maitre D
Ecol Evol; 2014 Apr; 4(8):1209-21. PubMed ID: 24834320
[TBL] [Abstract][Full Text] [Related]
24. Translation of preclinical ethnomedicine data in LMICs: the example of rooibos.
Pretorius L; Smith C
Front Pharmacol; 2023; 14():1328828. PubMed ID: 38174224
[TBL] [Abstract][Full Text] [Related]
25. The cardioprotective effect of an aqueous extract of fermented rooibos (Aspalathus linearis) on cultured cardiomyocytes derived from diabetic rats.
Dludla PV; Muller CJ; Louw J; Joubert E; Salie R; Opoku AR; Johnson R
Phytomedicine; 2014 Apr; 21(5):595-601. PubMed ID: 24268738
[TBL] [Abstract][Full Text] [Related]
26. Aspalathin and Nothofagin from Rooibos (Aspalathus linearis) inhibits high glucose-induced inflammation in vitro and in vivo.
Ku SK; Kwak S; Kim Y; Bae JS
Inflammation; 2015 Feb; 38(1):445-55. PubMed ID: 25338943
[TBL] [Abstract][Full Text] [Related]
27. Aspalathin improves glucose and lipid metabolism in 3T3-L1 adipocytes exposed to palmitate.
Mazibuko SE; Joubert E; Johnson R; Louw J; Opoku AR; Muller CJ
Mol Nutr Food Res; 2015 Nov; 59(11):2199-208. PubMed ID: 26310822
[TBL] [Abstract][Full Text] [Related]
28. Potential of rooibos, its major C-glucosyl flavonoids, and Z-2-(β-D-glucopyranosyloxy)-3-phenylpropenoic acid in prevention of metabolic syndrome.
Muller CJF; Malherbe CJ; Chellan N; Yagasaki K; Miura Y; Joubert E
Crit Rev Food Sci Nutr; 2018 Jan; 58(2):227-246. PubMed ID: 27305453
[TBL] [Abstract][Full Text] [Related]
29. Anti-inflammatory Effects of Aspalathin and Nothofagin from Rooibos (Aspalathus linearis) In Vitro and In Vivo.
Lee W; Bae JS
Inflammation; 2015 Aug; 38(4):1502-16. PubMed ID: 25655391
[TBL] [Abstract][Full Text] [Related]
30. Meta-analysis of the association between whole grain intake and coronary heart disease risk.
Tang G; Wang D; Long J; Yang F; Si L
Am J Cardiol; 2015 Mar; 115(5):625-9. PubMed ID: 25727082
[TBL] [Abstract][Full Text] [Related]
31. Whole grain and refined grain consumption and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of cohort studies.
Aune D; Norat T; Romundstad P; Vatten LJ
Eur J Epidemiol; 2013 Nov; 28(11):845-58. PubMed ID: 24158434
[TBL] [Abstract][Full Text] [Related]
32. Aspalathin from Rooibos (Aspalathus linearis): A Bioactive C-glucosyl Dihydrochalcone with Potential to Target the Metabolic Syndrome.
Johnson R; Beer D; Dludla PV; Ferreira D; Muller CJF; Joubert E
Planta Med; 2018 Jul; 84(9-10):568-583. PubMed ID: 29388183
[TBL] [Abstract][Full Text] [Related]
33. Bioavailability and antioxidant potential of rooibos flavonoids in humans following the consumption of different rooibos formulations.
Breiter T; Laue C; Kressel G; Gröll S; Engelhardt UH; Hahn A
Food Chem; 2011 Sep; 128(2):338-47. PubMed ID: 25212140
[TBL] [Abstract][Full Text] [Related]
34. Amelioration of lipopolysaccharide-induced liver injury by aqueous rooibos (Aspalathus linearis) extract via inhibition of pro-inflammatory cytokines and oxidative stress.
Ajuwon OR; Oguntibeju OO; Marnewick JL
BMC Complement Altern Med; 2014 Oct; 14():392. PubMed ID: 25312795
[TBL] [Abstract][Full Text] [Related]
35. Effects of black tea on body composition and metabolic outcomes related to cardiovascular disease risk: a randomized controlled trial.
Bøhn SK; Croft KD; Burrows S; Puddey IB; Mulder TP; Fuchs D; Woodman RJ; Hodgson JM
Food Funct; 2014 Jul; 5(7):1613-20. PubMed ID: 24889137
[TBL] [Abstract][Full Text] [Related]
36. Aspalathus linearis (Rooibos) - a functional food targeting cardiovascular disease.
Smith C; Swart A
Food Funct; 2018 Oct; 9(10):5041-5058. PubMed ID: 30183052
[TBL] [Abstract][Full Text] [Related]
37. Pu-erh tea polysaccharides decrease blood sugar by inhibition of α-glucosidase activity in vitro and in mice.
Deng YT; Lin-Shiau SY; Shyur LF; Lin JK
Food Funct; 2015 May; 6(5):1539-46. PubMed ID: 25820466
[TBL] [Abstract][Full Text] [Related]
38. Antidiabetic effect of green rooibos (Aspalathus linearis) extract in cultured cells and type 2 diabetic model KK-A(y) mice.
Kamakura R; Son MJ; de Beer D; Joubert E; Miura Y; Yagasaki K
Cytotechnology; 2015 Aug; 67(4):699-710. PubMed ID: 25410530
[TBL] [Abstract][Full Text] [Related]
39. Effects of consumption of rooibos (Aspalathus linearis) and a rooibos-derived commercial supplement on hepatic tissue injury by tert-butyl hydroperoxide in Wistar rats.
Canda BD; Oguntibeju OO; Marnewick JL
Oxid Med Cell Longev; 2014; 2014():716832. PubMed ID: 24738022
[TBL] [Abstract][Full Text] [Related]
40. Weight reduction effect of Puerh tea in male patients with metabolic syndrome.
Yang TY; Chou JI; Ueng KC; Chou MY; Yang JJ; Lin-Shiau SY; Hu ME; Lin JK
Phytother Res; 2014 Jul; 28(7):1096-101. PubMed ID: 24399768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
